Search research articles
Contact Us
Filters
Showing results (1-10 of 34) with videos related to
Page
of 4
Sort By:
International Journal of Hematology
|
June 25, 2021
Predictive and risk factor analysis for bloodstream infection in high-risk hematological patients with febrile neutropenia: post-hoc analysis from a prospective, large-scale clinical study
Akinao Okamoto, Yoshinobu Kanda, Shun-Ichi Kimura, et al.
Histopathology
|
February 24, 2017
Reappraisal of Epstein-Barr virus (EBV) in diffuse large B-cell lymphoma (DLBCL): comparative analysis between EBV-positive and EBV-negative DLBCL with EBV-positive bystander cells
Akiko Ohashi, Seiichi Kato, Akinao Okamoto, et al.
Cancer Genetics
|
October 30, 2012
A novel RUNX1-C11orf41 fusion gene in a case of acute myeloid leukemia with a t(11;21)(p14;q22)
Akihiro Abe, Akira Katsumi, Miki Kobayashi, et al.
Pathology International
|
November 20, 2018
Epstein-Barr virus (EBV)-positive diffuse large B-cell lymphoma arising in patient with a history of EBV-positive mucocutaneous ulcer and EBV-positive nodal polymorphous B-lymphoproliferative disorder
Teerada Daroontum, Kei Kohno, Yoko Inaguma, et al.
The Journal of Infection
|
October 28, 2021
Fungal biomarker monitoring and CT scans for early detection of invasive fungal disease in neutropenic hematological patients
Shun-Ichi Kimura, Yoshinobu Kanda, Tatsuo Oyake, et al.
Research and Practice in Thrombosis and Haemostasis
|
August 18, 2025
Prognostic relevance of early clinical and laboratory findings in immune-mediated thrombotic thrombocytopenic purpura
Atsushi Hamamura, Kazuya Sakai, Toshiki Mushino, et al.
Cancer Chemotherapy and Pharmacology
|
June 22, 2016
Evaluation of a method for calculating carboplatin dosage in DeVIC ± R therapy (combination therapy of dexamethasone, etoposide, ifosfamide and carboplatin with or without rituximab) as a salvage therapy in patients with relapsed or refractory non-Hodgkin lymphoma
Ayana Tomono, Kaori Ito, Takahiro Hayashi, et al.
Cytogenetic and Genome Research
|
June 17, 2020
Truncated RUNX1 Generated by the Fusion of RUNX1 to Antisense GRIK2 via a Cryptic Chromosome Translocation Enhances Sensitivity to Granulocyte Colony-Stimulating Factor
Akihiro Abe, Yukiya Yamamoto, Akira Katsumi, et al.
International Journal of Hematology
|
March 31, 2015
The fate of patients with acute myeloid leukemia not undergoing induction chemotherapy
Masamitsu Yanada, Akinao Okamoto, Yoko Inaguma, et al.
Chemico-Biological Interactions
|
February 27, 2016
In vitro antiproliferative activity of 2,3-dihydroxy-9,10-anthraquinone induced apoptosis against COLO320 cells through cytochrome c release caspase mediated pathway with PI3K/AKT and COX-2 inhibition
C Balachandran, N Emi, Y Arun, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 34) with videos related to
Sort By:
Page
of 4
International Journal of Hematology
|
June 25, 2021
Predictive and risk factor analysis for bloodstream infection in high-risk hematological patients with febrile neutropenia: post-hoc analysis from a prospective, large-scale clinical study
Akinao Okamoto, Yoshinobu Kanda, Shun-Ichi Kimura, et al.
Histopathology
|
February 24, 2017
Reappraisal of Epstein-Barr virus (EBV) in diffuse large B-cell lymphoma (DLBCL): comparative analysis between EBV-positive and EBV-negative DLBCL with EBV-positive bystander cells
Akiko Ohashi, Seiichi Kato, Akinao Okamoto, et al.
Cancer Genetics
|
October 30, 2012
A novel RUNX1-C11orf41 fusion gene in a case of acute myeloid leukemia with a t(11;21)(p14;q22)
Akihiro Abe, Akira Katsumi, Miki Kobayashi, et al.
Pathology International
|
November 20, 2018
Epstein-Barr virus (EBV)-positive diffuse large B-cell lymphoma arising in patient with a history of EBV-positive mucocutaneous ulcer and EBV-positive nodal polymorphous B-lymphoproliferative disorder
Teerada Daroontum, Kei Kohno, Yoko Inaguma, et al.
The Journal of Infection
|
October 28, 2021
Fungal biomarker monitoring and CT scans for early detection of invasive fungal disease in neutropenic hematological patients
Shun-Ichi Kimura, Yoshinobu Kanda, Tatsuo Oyake, et al.
Research and Practice in Thrombosis and Haemostasis
|
August 18, 2025
Prognostic relevance of early clinical and laboratory findings in immune-mediated thrombotic thrombocytopenic purpura
Atsushi Hamamura, Kazuya Sakai, Toshiki Mushino, et al.
Cancer Chemotherapy and Pharmacology
|
June 22, 2016
Evaluation of a method for calculating carboplatin dosage in DeVIC ± R therapy (combination therapy of dexamethasone, etoposide, ifosfamide and carboplatin with or without rituximab) as a salvage therapy in patients with relapsed or refractory non-Hodgkin lymphoma
Ayana Tomono, Kaori Ito, Takahiro Hayashi, et al.
Cytogenetic and Genome Research
|
June 17, 2020
Truncated RUNX1 Generated by the Fusion of RUNX1 to Antisense GRIK2 via a Cryptic Chromosome Translocation Enhances Sensitivity to Granulocyte Colony-Stimulating Factor
Akihiro Abe, Yukiya Yamamoto, Akira Katsumi, et al.
International Journal of Hematology
|
March 31, 2015
The fate of patients with acute myeloid leukemia not undergoing induction chemotherapy
Masamitsu Yanada, Akinao Okamoto, Yoko Inaguma, et al.
Chemico-Biological Interactions
|
February 27, 2016
In vitro antiproliferative activity of 2,3-dihydroxy-9,10-anthraquinone induced apoptosis against COLO320 cells through cytochrome c release caspase mediated pathway with PI3K/AKT and COX-2 inhibition
C Balachandran, N Emi, Y Arun, et al.
Page
of 4